APA

Goedegebuure P., Mitchem J. B., Porembka M. R., Tan M. C. B., Belt B. A., Wang-Gillam A., Gillanders W. E., Hawkins W. G. & Linehan D. C. (20111207). Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. : Current cancer drug targets.

Chicago

Goedegebuure P, Mitchem J B, Porembka M R, Tan M C B, Belt B A, Wang-Gillam A, Gillanders W E, Hawkins W G and Linehan D C. 20111207. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. : Current cancer drug targets.

Harvard

Goedegebuure P., Mitchem J. B., Porembka M. R., Tan M. C. B., Belt B. A., Wang-Gillam A., Gillanders W. E., Hawkins W. G. and Linehan D. C. (20111207). Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. : Current cancer drug targets.

MLA

Goedegebuure P, Mitchem J B, Porembka M R, Tan M C B, Belt B A, Wang-Gillam A, Gillanders W E, Hawkins W G and Linehan D C. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. : Current cancer drug targets. 20111207.